The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMYT.L Regulatory News (AMYT)

  • There is currently no data for AMYT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-yearly Report

22 Dec 2011 10:08

22 December 2011 Sterling Green Group plc ("Sterling Green" or "the Company") Half yearly results for the six month period ended 30 September 2011

CHAIRMAN'S STATEMENT

Introduction

I present the Group's interim results for the six month period ended 30 September 2011.

Partial disposal of the Group's debt management book

On 2 December 2011 it was announced that all of the conditions to the sale and purchase agreement referenced in the circular to shareholders dated 14 November 2011 had been satisfied. Gross proceeds amounting to approximately £957,000 relating to the partial disposal have since been received, with up to a maximum of a further £50,000 to be received which is subject to a retention clause. The retention monies are due to be released by 1 June 2012, being 6 months from the date of the completion of the partial disposal.

On 28 September 2011 it was announced that the Group had entered into a non-binding agreement to dispose of a significant part of the Group's trading operations, the effect of which would be to considerably reduce the size of the ongoing debt management business. The Directors have reviewed the criteria given in IFRS5 in respect of reporting discontinued operations, and have concluded that this criteria was satisfied. Accordingly, the estimated amounts of debt management activity that have been disposed of have been excluded from the condensed consolidated statement of comprehensive income for the period on a line by line basis and, instead, have been replaced by a single line headed profit on discontinued operations. Comparative periods have also been restated on a similar basis.

Results and dividend

As a result, the Group generated a loss before and after taxation for the six month period of £190,000 (six months ended 30 September 2010 - £38,000 profit). The loss from continuing operations amounted to £408,000 while the profit from discontinued operations was £218,000. The loss for the six month period is stated after inclusion of a goodwill impairment charge amounting to £108,000 which has been attributed to discontinued operations. The loss per share for the six month period was 0.06p (2010 - 0.01p profit per share) and the Directors do not recommend the payment of a dividend.

Disposals

On 21 December 2011 the Group disposed of its entire shareholdings in Taxdebts Limited and Sterling Green (Mortgages) Limited for the sum of £205. In addition, on the same date, Taxdebts Limited acquired the remaining small debt management book for a cash consideration of £10,000 while also taking over the responsibility for the ongoing employment of 12 members of staff. Tariq Ali is remaining as a director of Taxdebts Limited and Sterling Green (Mortgages) Limited and Jason McClean will become a consultant to Taxdebts Limited.

Under the AIM Rules for Companies, the sale of the remaining small debt management book is deemed to be a related party transaction, due to the involvement of Tariq Ali, a director of the Company. The independent directors of the Company, Michael Edelson, Philip Kanas and Ian Aspinall consider, having consulted with Merchant Securities Limited, that the terms of the transaction are fair and reasonable in so far as the Company's shareholders are concerned.

Board Changes

As a result of the completion of the disposal of all of the Company's trading business, Tariq Ali, Chief Executive, and Jason McClean, Operations Director, have resigned as directors of the Company, with immediate effect, to pursue their other business interests.

Outlook

Following completion of the partial disposal of the debt management book on 1 December 2011 and receipt of the disposal proceeds, the Group's borrowings have been repaid in full in order to significantly reduce ongoing finance costs. While the Group has continued with its remaining debt management activities on a reduced scale, the Directors have sought to reduce operating costs significantly with a view to preserving cash resources.

Since 1 December 2011, Sterling Green Group plc has been classified as an investing company under Rule 15 of the AIM Rules for Companies. As such, it is obliged to make an acquisition which constitutes a reverse takeover or otherwise have substantially implemented its investing policy by 1 December 2012, being 12 months from the date of the partial disposal. The Board is currently reviewing a number of possible opportunities and any acquisition will be put to shareholders for their approval at the appropriate time.

Michael EdelsonChairman22 December 2011Further Enquiries:Sterling Green Group plc Tel: 0161 975 5757 Michael Edelson Merchant Securities Limited Tel: 020 7628 2200 Simon Clements/David Worlidge

CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

FOR THE SIX MONTH PERIOD ENDED 30 SEPTEMBER 2011

Six months Six months Year ended ended ended 30 September 30 September 31 March 2011 2010 2011 (Unaudited) (Unaudited) (Audited) £000 £000 £000 Continuing operations Revenue 288 360 726 Cost of sales (178) (158) (386) Gross profit 110 202 340 Administrative expenses (448) (490) (1,011) Loss from operations (338) (288) (671) Finance costs (70) (27) (88) Loss on ordinary activities before (408) (315) (759)tax Income tax charge - - - Loss from continuing operations (408) (315) (759) Profit from discontinued operations 218 353 791 (Loss)/Profit for the period and (190) 38 32(loss)/profit attributable to equity holders of the parent (Loss)/Earnings per share - basic From continuing operations (0.13p) (0.10p) (0.25p) From discontinued operations 0.07p 0.11p 0.26p From continuing and discontinued (0.06p) 0.01p 0.01poperations (Loss)/Earnings per share - diluted From continuing operations (0.13p) (0.10p) (0.24p) From discontinued operations 0.07p 0.11p 0.25p From continuing and discontinued (0.06p) 0.01p 0.01poperations

There were no other items of comprehensive income other than the loss for the period.

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN TOTAL EQUITY

FOR THE SIX MONTH PERIOD ENDED 30 SEPTEMBER 2011

Six months Six months Year ended ended ended 30 September 30 September 31 March 2011 2010 2011 (Unaudited) (Unaudited) (Audited) £000 £000 £000 Balance at the beginning of the period 719 687 687 Total comprehensive income for the period (Loss)/Profit for the period (190) 38 32 Balance at the end of the period 529 725 719

CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION

AS AT 30 SEPTEMBER 2011 As at As at As at 30 September 30 September 31 March 2011 2010 2011 (Unaudited) (Unaudited) (Audited) £000 £000 £000 Non-current assets Goodwill - 1,115 1,115 Property, plant and equipment 79 89 89 Total non-current assets 79 1,204 1,204 Current assets Trade and other receivables 118 226 143 Cash and cash equivalents 7 76 44 Non-current assets held for sale 1,007 - - Total current assets 1,132 302 187 Total assets 1,211 1,506 1,391 Current liabilities Trade and other payables (225) (340) (243) Current tax liabilities - - - Borrowings (457) (24) (424) Total current liabilities (682) (364) (667) Net current assets/(liabilities) 450 (62) (480) Non-current liabilities Borrowings - (417) (5) Total non-current liabilities - (417) (5) Total liabilities (682) (781) (672) Net assets 529 725 719 Equity Share capital 304 304 304 Share premium account 1,794 1,794 1,794 Capital reserve 6 6 6 Other reserves 891 891 891 Accumulated losses (2,466) (2,270) (2,276) Total equity 529 725 719

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

FOR THE SIX MONTH PERIOD ENDED 30 SEPTEMBER 2011

Six months Six months Year ended ended ended 30 September 30 September 31 March 2011 2010 2011 (Unaudited) (Unaudited) (Audited) £000 £000 £000 Cash flows from/(used in) operating activities (Loss)/Profit before tax (190) 38 32 Adjustments for: Impairment of goodwill on 108 - -re-measurement Depreciation of property, plant and 29 31 62equipment Finance costs 70 27 88 Operating cash flows before movement in 17 96 182working capital Decrease/(increase) in trade and other 25 (118) (35)receivables Decrease in trade and other payables (18) (21) (118) Corporation tax paid - (1) (1) Net cash from/(used in) operating 24 (44) 28activities Cash flow used in investing activities Purchase of property, plant and (19) (4) (35)equipment Net cash used in investing activities (19) (4) (35) Cash flow (used in)/from financing activities Capital element of finance lease (12) (27) (39)payments Loans received 40 150 150 Finance costs (70) (27) (88) Net cash (used in)/from financing (42) 96 23activities Net (decrease)/increase in cash and (37) 48 16cash equivalents Cash and cash equivalents at the start 44 28 28of the period Cash and cash equivalents at the end of 7 76 44the period

NOTES TO THE INTERIM RESULTS

FOR THE SIX MONTH PERIOD ENDED 30 SEPTEMBER 2011

1. Reporting entity

Sterling Green Group plc (the "Company") is a company incorporated in the United Kingdom under the Companies Act 2006. The interim results of the Company for the six month period ended 30 September 2011 comprise the Company and its subsidiaries (together the "Group").

The annual report and financial statements of the Group for the year ended 31 March 2011 are available upon request from the Company's registered office by writing to the Company Secretary, Sterling Green Group plc, Number 14, The Embankment, Vale Road, Heaton Mersey, Stockport SK4 3GN or can be obtained from the Company's website which is www.sterlinggreen.co.uk.

2. Statement of compliance

These interim results have been prepared on the basis of the recognition and measurement requirements of IFRS anticipated to be in issue as either endorsed by the EU and effective (or available for early adoption) at 31 March 2012.

These interim results should be read in conjunction with the annual report and financial statements of the Group for the year ended 31 March 2011, which were approved for issue by the Directors on 11 November 2011, as it provides an update on previously reported information. The comparative figures for the year ended 31 March 2011 are not the Group's statutory financial statements for the financial year. They are, however, derived from the statutory financial statements for that year which have been delivered to the Registrar of Companies. The auditors report to those financial statements did not contain statements under sections 498 (2) or (3) of the Companies Act 2006, but was modified by an Emphasis of Matter paragraph relating to the uncertainty that existed at the reporting date regarding the partial disposal and funding of the business. As disclosed elsewhere, the partial disposal was completed on 1 December 2011. Following receipt of the proceeds of the partial disposal, and after taking into consideration future ongoing expenditure, the Directors have presented these interim results on a going concern basis.

These interim results were approved by the Board on 22 December 2011. The financial information contained therein for the six month period ended 30 September 2011, and similarly the six month period ended 30 September 2010, has neither been audited nor reviewed.

3. Significant accounting policies

The accounting policies used in the presentation of these interim results are consistent with those used in the annual report and financial statements of the Group for the year ended 31 March 2011.

4. Estimates

The preparation of interim results requires management to make judgements, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets and liabilities, income and expense. Actual results may differ from these estimates.

In preparing these interim results, the significant judgements made by management in applying the Group's accounting policies and the key sources of estimation uncertainty were the same as those that applied to the financial statements of the Group for the year ended 31 March 2011.

5. Operating segments

The Group's business segments are its debt management division, its re-mortgaging operations and its head office operations. This is the basis on which the Group reports its primary segmental information. In the table below, all revenues are generated by sales to external parties.

Debt Re- Unallocated Total Management mortgages Group items Continuing operations £000 £000 £000 £000 Performance by activity: Revenue: - six months ended 30 Sept 2011 235 53 - 288 - six months ended 30 Sept 2010 296 64 - 360 - year ended 31 March 2011 606 120 - 726 Operating profit/(loss):

- six months ended 30 Sept 2011 (270) 8 (76) (338)

- six months ended 30 Sept 2010 (220) 18 (86) (288)

- year ended 31 March 2011 (529) 33 (175) (671) Total assets: - 30 September 2011 1,192 12 7 1,211 - 30 September 2010 1,494 5 7 1,506 - 31 March 2011 1,375 11 5 1,391

The Group operates in a sector where no significant seasonal or cyclical variations in revenues and operating results are experienced during the financial year.

6. Discontinued operations

The table below shows the estimated amounts of the discontinued operations for the 6 month period ended 30 September 2011.

Six months Six months Year ended ended ended 30 September 30 September 31 March 2011 2010 2011 (Unaudited) (Unaudited) (Audited) £000 £000 £000 Revenue 913 962 2,075

Cost of sales and administrative costs (587) (609) (1,284)

Operating profit 326 353 791 Finance costs - - - Profit before and after tax from 326 353 791discontinued operations Impairment loss recognised on disposal (108) - - Profit from discontinued operations 218 353 791 Analysis of cash flow movements: Operating cash flows 326 353 7917. Financial risk management

The Group's financial risk management objectives and policies are consistent with those disclosed in the annual report and financial statements of the Group for the year ended 31 March 2011.

8. (Loss)/Earnings per share

The calculation of (loss)/earnings per share is based on the following:

(Loss)/Earnings Six months Six months Year ended ended ended 30 September 30 September 31 March 2011 2010 2011 Loss for the year from continuing (408) (315) (759)operations Earnings for the year from 218 353 791discontinued operations (Loss)/Earnings for the year from (190) 38 32continuing and discontinued operations Number of shares

Weighted average number of ordinary 303,675,390 303,675,390 303,675,390 shares for the purpose of basic

(loss)/earnings per share Effect of dilutive potential - 12,227,723 12,567,280ordinary shares - share options

Weighted average number of ordinary 303,675,390 315,903,113 316,242,670 shares for the purpose of diluted

(loss)/earnings per share (Loss)/Earnings per share (pence) - Basic Loss per share from continuing (0.13) (0.10) (0.25)operations Earnings per share form 0.07 0.11 0.26discontinued operations (Loss)/Earnings per share from (0.06) 0.01 0.01continuing and discontinued operations (Loss)/Earnings per share (pence) - Diluted Loss per share from continuing (0.13) (0.10) (0.24)operations Earnings per share form 0.07 0.11 0.25discontinued operations (Loss)/Earnings per share from (0.06) 0.01 0.01continuing and discontinued operations

The Company's potential ordinary shares, which consist of share options, would not be dilutive in the 6 month period ended 30 September 2011 due to the losses incurred.

9. Dividends

No dividend is proposed for the six month period ended 30 September 2011. No dividend was paid, in or proposed for, the year ended 31 March 2011.

10. Related parties

Key management receive compensation in the form of short term employee benefits, and they received the following amounts during the period:

Six months Six months Year ended ended ended 30 September 30 September 31 March 2011 2010 2011 £000 £000 £000 Directors remuneration: 110 133 273 Short term benefits

11. Analysis of cash and cash equivalents

Six months Six months Year ended ended ended 30 September 30 September 31 March 2011 2010 2011 £000 £000 £000 Bank balances 7 76 44

XLON
Date   Source Headline
6th Jan 20225:30 pmRNSAmryt Pharma
6th Jan 20227:00 amGNWKey Dates for AIM Delisting
4th Jan 202212:00 pmGNWThe Lancet Diabetes & Endocrinology Publishes Positive Results for the MPOWERED Phase 3 Trial for Mycapssa® (oral octreotide) in Acromegaly Patients
4th Jan 20227:00 amGNWTotal Voting Rights
1st Dec 20217:00 amGNWTotal Voting Rights
30th Nov 20217:00 amGNWDirector/PDMR Shareholding
23rd Nov 202112:00 pmGNWAmryt Provides Update on Regulatory Review Process for Oleogel-S10
22nd Nov 20217:00 amGNWAmryt Announces the Cancellation of Admission of its Ordinary Shares to Trading on AIM
3rd Nov 202111:00 amGNWAmryt Reports Strong Q3 2021 Results
1st Nov 20211:00 pmGNWTotal Voting Rights
1st Nov 20217:00 amRNSAmryt Supports Acromegaly Awareness Day
22nd Oct 20217:00 amRNSAmryt Supports Global EB Awareness Week 2021
20th Oct 202112:00 pmGNWAmryt to Report Q3 2021 Results and Host Conference Call & Webcast on November 3
19th Oct 202112:00 pmGNWAmryt Announces New Patents for Oleogel-S10 and Mycapssa®
23rd Sep 202112:00 pmRNSAmryt Supports Global FH Awareness Day
13th Sep 202112:00 pmGNWAmryt Raises Full Year 2021 Revenue Guidance to $220M - $225M
1st Sep 20217:00 amGNWTotal Voting Rights
19th Aug 20217:00 amGNWAmryt Issues Ordinary Shares and Total Voting Rights
13th Aug 20211:23 pmRNSHolding(s) in Company - Replacement
11th Aug 202111:30 amRNSHoldings in Company
11th Aug 202110:36 amRNSHolding(s) in Company
10th Aug 20212:20 pmGNWDirector/PDMR Shareholding
10th Aug 20219:53 amRNSHolding(s) in Company
9th Aug 202112:00 pmGNWAmryt Virtual Capital Markets Event - September 13, 2021 – 1000-1200 EDT
6th Aug 202112:00 pmGNWAmryt Reports Record Q2 2021 Results and Raises FY 2021 Guidance
5th Aug 20213:50 pmGNWAmryt Successfully Completes Acquisition of Chiasma, Inc., Board Appointments, Issues Ordinary Shares and Total Voting Rights
28th Jul 20213:00 pmGNWResult of General Meetings
12th Jul 202112:00 pmGNWAmryt to Report Q2 2021 Results and Host Conference Call & Webcast on August 6
28th Jun 202112:00 pmGNWPublication of Circular to Amryt Shareholders in relation to the acquisition of Chiasma, Inc., and posting of Annual Report and Notices of General Meetings
15th Jun 202111:45 amGNWAmryt Pharma Announces Filing of Preliminary Registration Statement on Form F-4 in Connection with Its Proposed Acquisition of Chiasma, Inc.
7th Jun 202112:00 pmGNWFDA confirms NDA for Oleogel-S10 will not require an Advisory Committee Meeting
3rd Jun 20217:00 amGNWFDA Grants Priority Review for New Drug Application for Oleogel-S10 for the Treatment of Epidermolysis Bullosa
2nd Jun 20211:30 pmGNWAmryt Announces FDA Acceptance of New Drug Application for Oleogel-S10 for the Treatment of Epidermolysis Bullosa
5th May 20214:41 pmRNSSecond Price Monitoring Extn
5th May 20214:35 pmRNSPrice Monitoring Extension
5th May 202112:05 pmGNWAmryt Reports Record Q1 2021 Financial and Operating Results
5th May 202112:00 pmGNWAmryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership in Rare and Orphan Diseases
15th Apr 202112:00 pmGNWAmryt to Report Q1 2021 Results and Host Conference Call & Webcast on May 5
6th Apr 20217:00 amGNWAmryt Announces the Appointment of Sheila Frame as President Americas
31st Mar 202111:00 amRNSAmryt Supports World Lipodystrophy Day
31st Mar 20217:00 amGNWAmryt Submits a New Drug Application to the US Food and Drug Administration for Oleogel-S10* (Filsuvez®)
30th Mar 20217:00 amGNWAmryt Announces Results from an Investigator Sponsored Study of Lomitapide in FCS
29th Mar 20217:00 amGNWAmryt Announces Validation of its MAA by the EMA for Oleogel-S10* (Filsuvez®)
23rd Mar 20217:00 amGNWAmryt Receives Positive Feedback from the FDA on the Path Forward for Myalept® (metreleptin) Indication in Partial Lipodystrophy
22nd Mar 20217:00 amGNWAmryt Receives Reimbursement Approval from the French Ministry of Social Affairs and Health for Myalepta® (metreleptin)
15th Mar 202110:00 amGNWDirector/PDMR Shareholding
12th Mar 20217:00 amGNWExercise of Options and Total Voting Rights
11th Mar 202111:30 amGNWExercise of Warrants & Issue of Ordinary Shares and Total Voting Rights
8th Mar 20216:00 pmGNWDirector/PDMR Shareholding
8th Mar 20217:00 amGNWAmryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.